about
Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study.Loss of VPS13C Function in Autosomal-Recessive Parkinsonism Causes Mitochondrial Dysfunction and Increases PINK1/Parkin-Dependent MitophagyComprehensive research synopsis and systematic meta-analyses in Parkinson's disease genetics: The PDGene database.Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.Cooperative genome-wide analysis shows increased homozygosity in early onset Parkinson's disease.EIF4G1 mutations do not cause Parkinson's disease.A systematic screening to identify de novo mutations causing sporadic early-onset Parkinson's disease.Polygenic risk of Parkinson disease is correlated with disease age at onset.Is the MC1R variant p.R160W associated with Parkinson's?A pathway-based analysis provides additional support for an immune-related genetic susceptibility to Parkinson's disease.Genome-wide analysis of genetic correlation in dementia with Lewy bodies, Parkinson's and Alzheimer's diseases.Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.Genetic comorbidities in Parkinson's disease.Genetic risk and age in Parkinson's disease: Continuum not stratum.No clear support for a role for vitamin D in Parkinson's disease: A Mendelian randomization study.Establishing the role of rare coding variants in known Parkinson's disease risk loci.Increased brain expression of GPNMB is associated with genome wide significant risk for Parkinson's disease on chromosome 7p15.3.Variation in PARK10 is not associated with risk and age at onset of Parkinson's disease in large clinical cohorts.A meta-analysis of genome-wide association studies identifies 17 new Parkinson's disease risk loci.CHCHD2 and Parkinson's disease.ADORA1 mutations are not a common cause of Parkinson's disease and dementia with Lewy bodies.
P50
Q28681958-64C91161-7B77-4F0E-BEEA-D571C586246DQ29147504-9965AF30-F6FB-4D6F-9E4F-FB529DCA6EA3Q29417106-32B6836A-CABE-44A6-B18A-B02B6D04D415Q31063778-DC679E18-D12D-4F91-9B55-8212EF8CFED7Q34199600-041DDE0B-6DFC-4EC6-A41F-FD3944765CBCQ35732432-424930C8-EFE7-4B74-A18B-F3B996323AB4Q36251993-D5163E1C-20CD-4B36-A1C1-5B8F81DBBBEDQ36532888-879ECC76-EF8F-47CC-BDA6-B28BDD87E8C6Q36535790-85BF8C6E-EE9D-468D-B0BC-2BBF2F22D46CQ36580714-EA616B69-AC5A-4C6E-987B-251D575E94A8Q36595652-4C635F22-53D2-437A-BD82-B77E88787B9DQ36622356-4E5F82F0-D753-4687-8FD4-1BEE21B07698Q36822049-5ADAA62D-6DE0-42DF-A71F-3115CAD583E1Q37464009-0EB560A2-BBD6-41CA-970A-F759F875291DQ37566664-3B286E81-9830-4BE5-BEFF-35C400DFB8FCQ38736768-F4CB9C05-B739-49EE-9172-80502703A4F4Q40059954-40A53687-0BDB-4E57-879B-76E8A8D94B52Q41095173-5C0AD175-79AD-4239-B36C-E69D09FDAB04Q41496497-EBF04101-473D-486E-80F1-52533D9CEE4CQ47823702-25BA4685-3110-4017-BF8F-7B08D7E07E9BQ48132939-993C780C-2ECB-444B-8004-AA133D45A335Q48392446-EFE8D4A0-BCBB-4300-9FA4-B1F17176C921
P50
name
International Parkinson's Disease Genomics Consortium
@en
type
label
International Parkinson's Disease Genomics Consortium
@en
prefLabel
International Parkinson's Disease Genomics Consortium
@en